Willow Biosciences Inc. (WLLW.TO) TSX
Currency In CAD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 8.75M |
| Enterprise Value | 10.38M |
| P/E Ratio | -2.1 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 2.93 |
| Price/Book Ratio | 0.03 |
| Enterprise/Revenue | -13.62 |
| Enterprise/EBITDA | 21.24 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
Profitability
| Profit Margin | 0.03 |
| Operating Margin | -0.73 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0 |
Income Statement
| Revenue | 4.66M |
| Revenue/Share | 0.07 |
| Gross Profit | 3.28M |
| EBITDA | -4.54M |
| Net Income | -6.19M |
| Diluted EPS | -0.05 |
Balance Sheet
| Total Cash | 29.22M |
| Total Cash/Share | 1.15 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 32.23 |
| Book Value Per Share | 1.13 |
Price History
| 52-Week Change | -65 |
| 52-Week High | 0.73 |
| 52-Week Low | 0.03 |
| Moving Average 50 Days | 0.14 |
| Moving Average 200 Days | 0.25 |
Statistics
| Average Volume | 144,583 |
| Shares Outstanding | 147.2M |
| % Held by Institutions | 1.69 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
